StockData
OPKO Health, Inc. logo

OPKO Health, Inc. (OPK) stock

OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.57−0.04 (-2.48%)

Close on Nov 20, 2026Market cap $1.17BP/E –Yield –

OPKO Health gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

OPKO Health's gross profit for the twelve months ending Jun 30, 2026 was $239.69M, up 10.6% year over year. For fiscal 2025 it was $205.94M, down 5.8% from the year before. Over ten years it grew 34.4% a year on average. The highest annual figure on record is $1.07B in fiscal 2016.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$205.94M-5.8%
FY2024Dec 31, 2024$218.51M-31.3%
FY2023Dec 31, 2023$318.13M+10.4%
FY2022Dec 31, 2022$288.22M-68.1%
FY2017Dec 31, 2017$904.83M-15.4%
FY2016Dec 31, 2016$1.07B+137.9%
FY2015Dec 31, 2015$449.80M+450.2%
FY2014Dec 31, 2014$81.75M-5.1%
FY2013Dec 31, 2013$86.11M+349.3%
FY2012Dec 31, 2012$19.17M+78.5%
FY2011Dec 31, 2011$10.74M-28.4%
FY2010Dec 31, 2010$15.00M+872.7%
FY2009Dec 31, 2009$1.54M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$80.02M+62.0%
Q1 FY2026Mar 31, 2026$45.76M+7.4%
Q4 FY2025Dec 31, 2025$64.03M-24.4%
Q3 FY2025Sep 30, 2025$49.89M+24.3%
Q2 FY2025Jun 30, 2025$49.40M-4.4%
Q1 FY2025Mar 31, 2025$42.62M+1.3%
Q4 FY2024Dec 31, 2024$84.66M-64.8%
Q3 FY2024Sep 30, 2024$40.13M-72.2%
Q2 FY2024Jun 30, 2024$51.65M-77.5%
Q1 FY2024Mar 31, 2024$42.07M-84.9%
Q1 FY2018Mar 31, 2018$240.27M-4.5%
Q4 FY2017Dec 31, 2017$144.25M-45.2%
Q3 FY2017Sep 30, 2017$229.93M-19.4%
Q2 FY2017Jun 30, 2017$279.10M–
Q1 FY2017Mar 31, 2017$251.55M–
Q4 FY2016Dec 31, 2016$263.14M–
Q3 FY2016Sep 30, 2016$285.41M–

More OPKO Health figures

See a number that looks wrong?